Telomeres have an essential role in ensuring that the natural ends of chromosomes are not mistaken for sites of DNA damage. Telomere function depends on three factors: telomeric DNA, the shelterin complex and the telomerase complex (FIG. 1) . Human and mouse telo meres are composed of a long doublestranded array of TTAGGG repeats bound by the sixsubunit shelterin complex (BOX 1; FIG. 1). Shelterin represses the DNA damage response (DDR) at telomeres, thereby preventing the activation of the kinases ATM and ATR that can induce cell cycle arrest in response to DNA double strand breaks (DSBs) and other types of DNA damage. In addition, shelterin ensures that telomeres are not processed by sev eral DSB repair pathways, including the non-homologous end joining (NHEJ) pathway that could lead to chromo some end fusions. Shelterin partially protects telomeres by forming the tloop structure by which the telomere terminus is hidden (FIG. 1) . Tloops are formed through strand invasion of the long 3′ overhang at the telo mere end into the doublestranded telo meric DNA. This 3ʹ overhang is recreated after DNA replication through exo nucleolytic degradation of the 5ʹ ends of the telomeres (FIG. 2a) . As a result of this processing and the inability of DNA polymerases to duplicate the ends of linear DNA molecules, human telomeres shorten by ~50 bps per cell division. This telomere attrition can be counteracted by telomerase reverse transcriptase (TERT) (FIG. 1) , which adds GGTTAG repeats to the chromosomal 3ʹ DNA terminus at the end of the chromosome.
During human development, telomerase activity is downregulated through the silencing of TERT, which encodes the reverse transcriptase subunit of the com plex. As a result, most human somatic cells (with the exception of certain stem cells) undergo programmed telomere shortening. Eventually, the loss of telomeric DNA leads to insufficient chromosome end protection and to the activation of the DDR, which will arrest cell proliferation and can induce senescence or apoptosis. The repression of telomerase in somatic cells and the resulting telomere proliferation barrier have the hall marks of a tumour suppressor pathway that limits tumour cell outgrowth after a delay. New evidence, reviewed below, argues that telomere shortening indeed protects against tumour development. Eventually, how ever, in incipient cancer cells that lack the pathways necessary for cell cycle arrest, mounting telomere dys function becomes a source of genomic instability in a stage referred to as telomere crisis [1] [2] [3] . The escape from telomere crisis requires the activation of telomerase, which reconstitutes telomere function and restores proliferative capacity. The outcome of this scenario is a telomerasepositive, transformed cell with a heavily rearranged, but stabilized, genome that has attained new and potentially tumorigenic genetic mutations.
Cancer genomes are characterized by extensive chromosome rearrangements that facilitate oncogenic progression 4 . The unexpected extent and staggering complexity of these rearrangements, which include deletions and amplifications, translocations, chromo thripsis, kataegis and tetraploidization, has only been appreciated in recent years 5 . Although there are many potential mechanisms underlying these rearrange ments 6 , new data have linked telomere dysfunction to a near comprehensive list of cancerrelevant genome alterations 2, 3, [7] [8] [9] , suggesting that telomere crisis contrib utes to the genetic disorder that is typical of cancer 10 . Here, we review these new data on the role of telomeres in genome instability in cancer and discuss new find ings pertaining to the role of telomere shortening in tumour suppression.
Tumour suppression by short telomeres
Telomere shortening in human cells has long been thought to represent a tumour suppressor mechanism. Although mouse models have previously illustrated this potentially advantageous aspect of telomere attrition, recent data now provide evidence for this proliferative barrier in human cancer cells.
Silencing of telomerase and telomere shortening.
Telomerase is a reverse transcriptase that synthesizes telomeric DNA de novo using integral RNA as the tem plate and the 3ʹ end of the chromosome as the primer 11-17 (FIG. 1) . The core components of telomerase are the reverse transcriptase TERT and telomerase RNA component (TERC), which provides the template for the synthesis of telomeric DNA. Telomerase is associated with a set of accessory proteins, including dyskerin, nucleolar protein 10 (NOP10), nonhistone protein 2 (NHP2), GAR1 and telomerase Cajal body protein 1 (TCAB1), that contrib ute to the biogenesis and trafficking of telomerase inside the nucleus 18, 19 (for reviews, see REFS 17, 20, 21) . TERT silencing downregulates telomerase activ ity in human somatic cells (reviewed in REF. 22 ). The other components of telomerase, including TERC, are expressed widely; thus, the expression of exogenous TERT is sufficient to activate telomerase in many primary human cells 23 . However, TERC expression can still be a limiting factor and the coexpression of TERT and TERC is needed for robust telomerase catalytic activity in some cell types 21, 24, 25 . Telomerase activation and the resulting telomerelength maintenance leads to the bypass of senescence and ultimately to cell immortalization 23, 26, 27 . The programmed silencing of TERT, loss of telo merase activity and the resulting shortening of telomeres is not a universal phenomenon in mammals. Apparently, this tumour suppressor pathway is restricted to large animals with a reproductive strategy that requires a long lifespan 28 . For example, telomerase activity is repressed in somatic cells of elephants but not in mice.
In the absence of telomerase, each human telo mere shortens at a rate of 50-100 bps per population doubling 29 . The rate of telomere attrition is partly due to the inability of DNA polymerases to copy the end of linear DNA (FIG. 2a) . The 5ʹ end resection that generates the telomeric 3ʹ overhang contributes substantially to the rate of telomere shortening 30 (FIG. 2a) . Shelterin governs this processing and the formation of the correct struc ture of the telomere terminus in mouse cells and most likely in human cells. The process involves the initiation of resection by the shelterinbound Apollo nuclease, further resection by exonuclease 1 (EXO1) and finally a fillin synthesis step mediated by the shelterinbound Figure 1 | Composition and structure of the human telomere system. Human telomeres comprise three components: telomeric DNA, the shelterin complex and the telomerase complex. Telomeric DNA consists of a long array of double-stranded TTAGGG repeats that culminates in a 50-300 nucleotide (nt) single-stranded 3ʹ overhang. This 3ʹ overhang invades double-stranded telomeric repeats to form a t-loop structure that is crucial for telomere function. Telomeric DNA protects chromosome ends through its association with the six-subunit shelterin complex. The length of telomeric repeats can be maintained by telomerase, which is composed of telomerase reverse transcriptase (TERT), telomerase RNA template component (TERC) and several accessory proteins (blue). TERT synthesizes telomeric DNA de novo using TERC as a template, whereas the accessory factors contribute to the biogenesis and nuclear trafficking of telomerase. DKC, dyskerin; NHP2, non-histone protein 2; NOP10, nucleolar protein 10; POT1, protection of telomeres 1; RAP1, repressor/activator protein 1; TCAB1, telomerase Cajal body protein 1; TIN2, TRF1-interacting nuclear factor 2; TRF, telomeric repeat-binding factor. 
Hayflick limit
The finite proliferation potential of primary human cells.
CST (CTC1-STN1-TEN1) complex [31] [32] [33] [34] [35] [36] [37] [38] (FIG. 2a) . Owing to this regulated terminal sequence loss, the proliferative lifespan of primary human cells (known as the Hayflick limit) is partly determined by how shelterin controls resection and fillin at telomeres. It will be interesting to determine whether the lifespan of human cells can be extended by diminishing the extent of 5ʹ end resection.
Telomere-induced senescence. Loss of telomere function at a few chromosome ends in a cell is sufficient to induce replicative arrest 9,39,40 (FIG. 2b) . The point at which telo mere attrition results in the loss of telomere protection at one or a few chromosome ends is dependent on the rate of telomere shortening, the initial telomere length and, importantly, the length of the shortest telomeres in the cells 41 . Because human telomeres are heterogeneously sized, several very short telomeres can be present in cells with an apparently ample telomere reserve, which makes measurements of bulk telomere length an imprecise predictor of cellular proliferative potential.
Senescent human fibroblasts display the molecu lar hallmarks of an activated DDR 39 , including ATM and ATR signalling, and nuclear foci containing DNA damage markers, such as γH2AX, p53binding pro tein 1 (53BP1) and mediator of DNA damage checkpoint protein 1 (MDC1). Upregulation of p53 and induction of the cyclindependent kinase (CDK) inhibitors p21 and p16 are also indicators of an activated DDR 42, 43 . The inactivation of shelterin similarly activates DNA damage signalling pathways, results in the upregulation of p21 and p16, and leads to the accumulation of DDR factors at telomeres, thus linking telomere dysfunction and senescence 39, 42 . Proof that replicative senescence is due to telomere shortening came from the bypass of senescence upon TERT expression 23 . Furthermore, over expression of the shelterin subunit telomeric repeat binding factor 2 (TRF2; also known as TERF2) can delay the onset of senescence 44 , arguing that the DDR in senes cence is due to an insufficient loading of shelterin at the shortened telomeres.
Box 1 | The shelterin complex and its functions
Shelterin is a complex comprising the following six subunits: telomeric repeat-binding factor 1 (TRF1), TRF2, repressor/ activator protein 1 (RAP1), TRF1-interacting nuclear factor 2 (TIN2), TPP1 (also known as adrenocortical dysplasia protein homologue) and protection of telomeres 1 (POT1) (see the figure). Shelterin associates with mammalian telomeres, where it regulates various aspects of telomere function [175] [176] [177] . Shelterin is recruited to telomeres through TRF1 and TRF2, which bind to double-stranded telomeric DNA and to TIN2. POT1 binds to single-stranded telomeric DNA and is linked to TRF1 and TRF2 through its binding partner TPP1, which associates with TIN2. RAP1 associates with TRF2.
Shelterin maintains telomere length and preserves genome integrity by regulating the access of telomerase to chromosome ends by controlling end-resection at newly replicated telomeres, and by masking telomeres from the DNA damage response (DDR). Specifically, TRF2 represses ATM-dependent DNA damage signalling and classical nonhomologous end joining (c-NHEJ), whereas POT1 is responsible for repressing ATR signalling and cooperates with RAP1 in suppressing homologous recombination. Avoiding the DDR is partially mediated by TRF2-dependent t-loop formation. T-loops are formed through the invasion of the 3ʹ overhang at the telomere end into double-stranded telomeric DNA (FIG. 1) , and is thought to prevent ATM activation by masking the chromosome end from the double-strand breaks sensor complex MRE11-RAD50-NBS1 (MRN) and by blocking c-NHEJ induction by preventing the loading of the Ku70-Ku80 heterodimer on the chromosome end. Repression of ATR signalling by POT1 involves occlusion of the single-stranded DNA sensor replication protein A (RPA). Importantly, this repression depends on the association of POT1 with the rest of shelterin via its interaction with TPP1. Telomere protection is compromised when telomeres become too short to support sufficient shelterin binding.
Shelterin also functions to facilitate telomere maintenance by the reverse transcriptase complex telomerase (FIG. 1) , which is recruited to telomeres by the shelterin components TPP1 and TIN2 (REFS 182, 183) . Shelterin also has a role in the regulation of telomerase-mediated telomere length maintenance (reviewed in REF. 184 ). Several shelterin subunits are negative regulators of telomere length, suggesting that shelterin subunits 'count' telomeric repeats to regulate telomerase activity and limit telomere length as part of a cis-acting negative-feedback loop (reviewed in REF. 185 ). This regulatory pathway may be important in the germ line, in which telomere length needs to be maintained within a narrow range to provide offspring with telomeres that are sufficiently long for normal development and tissue homeostasis, whereas at the same time are sufficiently short to suppress cell transformation by inducing replicative senescence.
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Senescent cells are usually in G1 phase, consistent with p53 activation and induction of the CDK inhibitors p21 and p16. The upregulation of p16 and the accom panying hypophosphorylation of the tumour suppres sor RB can contribute to telomereinduced senescence. Moreover, inactivation of both the RB and the p53 responses to dysfunctional telomeres is needed to com pletely circumvent this block to proliferation 43 . Because the complete bypass of telomere shorteninginduced senescence in human cells requires the inactivation of multiple pathways, this mechanism of curbing the pro liferation of transformed cells is likely to be robust 43, [45] [46] [47] [48] . By contrast, p53 inactivation alone is sufficient to avoid telomereinduced senescence and apoptosis in mice 49, 50 .
Telomere shortening, telomerase downregulation and cancer prevention. Experiments in genetically altered mice support the view that telomere shortening can act as a strong barrier to tumorigenesis (FIG. 2b) . Crosses of telomerasedeficient mice with various tumour model mice have demonstrated that critically short telomeres limit tumour formation when the p53 pathway is func tional [51] [52] [53] [54] [55] . In addition, the original demonstration that telomerase is active in most human cancers, whereas the enzyme is undetectable in normal tissues, suggested that the telomere tumour suppressor pathway may oper ate in most cancer types 56 . However, the upregulation of telomerase expression could be an irrelevant conse quence of transcriptional rewiring during tumori genesis, perhaps reflecting a stem cell phenotype in cancer. The recent identification of activating mutations in the TERT promoter in several cancer types argues strongly that these tumours had undergone selection for the activation of telomerase 57, 58 . Similarly, the amplifica tion of TERT and other mutations that increase telo merase activity in some cancers argue in favour of a selected phenotype [59] [60] [61] . A strong argument in support of the telomere tumour suppressor pathway emerged recently from a study of a large family with a predisposition to melanoma 58 . A link age analysis and highthroughput sequencing identi fied an activating mutation in the TERT promoter that cosegregates with disease predisposition. This mutation (T>G; 57 bp upstream of the transcription start site) creates a binding motif for ETS (E26 transformation specific) transcription factors. Thus, tissues that express ETS transcription factors are predicted to maintain telo merase activity, presumably resulting in the maintenance of telomere length and the consequent disruption of the telomere tumour suppressor pathway.
A similar example is provided by the recently identi fied melanomapredisposing mutations in the gene encoding the protection of telomeres 1 (POT1) sub unit of shelterin 62, 63 . These mutations alter POT1 mRNA splicing or compromise the oligonucleotide and/or oligosaccharidebinding folds in the singlestranded DNAbinding domains of POT1. As a consequence, the ability of POT1 to bind to singlestranded telo meric DNA is diminished. Carriers of these mutations have longer telomeres, presumably owing to the loss of POT1mediated inhibition of telomerase Incomplete DNA synthesis at the end of the lagging strand (at the site of the terminal RNA primer) leaves a short 3ʹ overhang. Additional loss of telomeric DNA occurs through the processing of the leading-strand ends of telomeres to regenerate the 3ʹ overhang, which is necessary for t-loop formation and the structural integrity of the telomere. This process is carried out by the nuclease Apollo, which is bound to telomeric repeat-binding factor 2 (TRF2). Both the leading end and the lagging end of telomeres are further resected by exonuclease 1 (EXO1) to generate transient long overhangs. The CST (CTC1-STN1-TEN1) complex then binds to shelterin and mediates fill-in synthesis of the cytosine-rich strand (C-strand) at both ends. b | During development, telomerase is switched off through telomerase reverse transcriptase (TERT) silencing. As a result, telomeres experience the gradual attrition described in part a. After numerous population doublings, a few telomeres become too short (yellow) and lose their protective function. As a result, the kinases ATM and ATR are activated at the unprotected chromosome ends and this DNA damage response (DDR) signalling induces replicative arrest and senescence or apoptosis. This process limits the proliferative capacity of incipient cancer cells, thus functioning as a tumour suppressor pathway. Cells lacking p53 and RB function can avoid this replicative arrest.
Dicentric chromosomes
Abnormal chromosomes with two centromeres that can result from telomere-telomere fusion.
Because the increased telomere length is present at birth, these mutations are likely to push the onset of senescence to later population doublings, thus post poning the tumoursuppressive effects of telomere attrition to a point of irrelevance. However, whether the diminished POT1 function also promotes genome instability is currently unknown 64 . Another observation in support of the telomere tumour suppressor pathway is that longer telomere length has been associated with an increased risk of B cell lymphoma and chronic lymphocytic leukaemia (CLL) [65] [66] [67] . In a recent study, singlenucleotide poly morphisms in telomere maintenance genes that are associated with telomere length 68, 69 were examined to determine the cancer risk of 95,568 individuals from the general population 70 . This analysis found that genetic determinants of long telomeres are associated with an increased overall cancer risk, especially lung cancer and melanoma. Collectively, these data are consist ent with telomere shortening functioning as a tumour suppressor pathway.
Telomere crisis and genome instability Although the telomere tumour suppressor pathway may be a powerful mechanism to limit cancer development, failure of transformed cells to undergo senescence can produce telomere crisis, during which the cell popula tion does not expand. In telomere crisis, cells struggle with a high level of genome instability owing to the presence of many dysfunctional telomeres. Activation of telo merase provides a path out of telomere crisis, ultimately leading to the formation of a cancer clone with a heavily rearranged genome (FIG. 3) .
Continued growth past the senescence barrier can occur in cells that lack the p53 and RB tumour sup pressor pathways, rendering their cell cycle transitions impervious to inhibition through ATM and ATR sig nalling. Continued telomere shortening eventually leads to cells with numerous dysfunctional telomeres, thereby increasing the chance that one dysfunctional telomere becomes fused to another. Consequently, cells in telomere crisis have endtoend fused dicentric chromo somes, which lead to mitotic missegregation and genomic instability. Cells in telomere crisis undergo frequent cell death. A common assumption is that this loss of viability is driven by chromosome breakage and missegregation, although it may also involve additional telomere deprotection during an extended mitotic arrest that occurs in some of the cells 71, 72 . Mammalian cells can use two types of endjoining pathways to repair DSBs: classical NHEJ (cNHEJ) and alternative NHEJ (altNHEJ) 73, 74 . cNHEJ relies on the Ku70-Ku80 heterodimer and DNA ligase 4 and can either be accurate or result in small deletions. By con trast, altNHEJ, which is mediated by poly(ADP ribose) polymerase 1 (PARP1) and DNA ligase 3, creates inser tions and more extensive deletions. Telomere fusions formed during telomere crisis in cultured cells are mediated by altNHEJ and exhibit insertion of new sequences at the fusion point 75, 76 . Similarly, altNHEJ has been implicated in telomere fusion in human cancer 77, 78 and in telomere fusions in mouse models 79 . By con trast, when telomeres are compromised through the loss of TRF2, their repair is carried out by cNHEJ [80] [81] [82] . The reason for this difference is not yet clear.
Genome instability in cells undergoing telomere crisis was initially found to give rise to chromosome gains and losses (aneuploidy), translocations, gene loss (manifested as loss of heterozygosity (LOH)) and regional amplification through breakage-fusion-bridge (BFB) cycles 1,80,83 . However, it has recently become clear that the repertoire of genomic alterations that can be ascribed to telomere crisis is more extensive and includes wholegenome reduplication, chromothripsis and kataegis 3, 8, 9 . BFB cycles and their associated chromosomal rearrangements. BFB cycles, first observed more than half a century ago by Barbara McClintock 84 , can occur when dicentric chromosomes (including those formed by telomere fusion) break, followed by a second fusion of the broken ends in the daughter cell 85 (FIG. 4a) . Telomere fusions can occur between different chromosomes or between sister chromatids after DNA replication, thus leading to different outcomes 86 . Collectively, BFB cycles can lead to three outcomes that are pertinent to cancer: LOH, nonreciprocal translocations and gene amplification.
LOH, which is frequent at cancerrelevant loci, can occur when a dicentric chromosome breaks and one of the daughter cells inherits a chromosome with a ter minal deletion (FIG. 4b) . Nonreciprocal translocations could arise when the DNA end of a broken chromo some invades another chromosome and copies part Nature Reviews | Molecular Cell Biology Loss of the RB and p53 tumour suppressor pathways disables the ability of cells to respond with cell cycle arrest to ATR and ATM signalling. As the cells continue to divide, their telomeres continue to shorten. Once many telomeres become too short to function, the unprotected chromosome ends generate end-to-end fusions and dicentric chromosomes, leading to many forms of genome instability. Ultimately, telomerase reactivation provides a route out of telomere crisis by healing critically shortened telomeres and improving genomic stability, thereby increasing cell viability. The resulting tumour will have active telomerase and a heavily rearranged genome.
Break-induced replication
An origin of replicationindependent replication restart that is initiated by the invasion of resected DNA into homologous sequences.
Micronuclei
Abnormal, small nuclei containing one or more chromosome (fragments); often formed as a result of mitotic chromosome segregation defects.
Lamin
An intermediate filament protein that imparts structural rigidity to the nucleus by assembling into a meshwork at the inner nuclear membrane.
of this chromosome through a process called breakinduced replication 87, 88 . Nonreciprocal trans locations occur during tumorigenesis in mice with shortening telomeres 1 and are a frequent class of rearrange ments in cancer 89 . Sequence analysis of more than 1,000 telo mere fusion events has shown that a chromo some end lacking telomere protection can recombine with diverse chromosomeinternal loci 90 . Gene amplification can result when the telomere fusion event involves sister chromatids, thus creating a large palindrome (FIG. 4b) . Subsequent asymmetric breakage of such an isochromosome and multiple BFB cycles can then generate amplicons that are organized in inverted repeats 91 . BFB cycles have been demon strated to initiate gene amplification in human cancer cells and in hamster cells [92] [93] [94] . Moreover, the inverted amplicon arrangements that are typical of BFB cycles have been observed in many cancer types, including pancreatic cancer, oesophageal cancer, breast cancer and leukaemias 91, [95] [96] [97] [98] .
Chromothripsis. Recently, chromothripsis was shown to be one of the outcomes of experimentally induced telomere crisis. Chromothripsis is a mutagenic process whereby one or more chromosomal regions undergo catastrophic shattering in a single event, followed by an apparently haphazard repair of the DNA fragments. This process results in genomes in which one or few chromosome segments are affected by tens to hundreds of genomic rearrangements 99 . Chromothripsis has been observed in diverse tumour types, especially those with p53 loss 100, 101 , and several studies have noted an associ ation between BFB cycles and chromothripsis 91, 98, 102 . Consistent with these associations, chromothripsis was demonstrated to be the result of telomere crisis induced by the inactivation of the shelterin subunit TRF2 in p53deficient and RBdeficient epithelial cells 3 . This study used livecell imaging to determine the fate of dicentric chromosomes formed during telomere crisis and showed that dicentric chromosomes do not break during mitosis. This finding was in agreement with work in yeast cells and a subsequent analysis in human cells 3,103,104 (FIG. 5a) . These dicentric chromosomes invari ably persist through mitosis and form long chromatin bridges that connect the daughter cells well into the next G1 phase 3 . These chromatin bridges contain a nuclear envelope that is contiguous with the nuclear envelop of the connected nuclei. However, when chromatin bridges are formed, there is frequent rupture of the nuclear envel ope of the connected nuclei, resulting in mixing of the nuclear and cytoplasmic contents. Spontaneous nuclear envelope rupture has been observed in cancer cell lines and is frequent in micronuclei 105, 106 . It is not clear how chromatin bridges induce nuclear envelope rupturing, but lamin depletion from the nuclear envelope may have a role as lamin B1 overexpression suppressed the ruptures, and lamin depletion can promote envelope rupture in cancer cell lines 3, 105 . A second source of nuclear envelope rupture may be the deformation of the two nuclei con nected by the stretching chromatin bridge. The dicentric chromosome in the bridge seems to exert pulling forces on the nuclear envelope, perhaps because it is attached to the nuclear lamins 107 . In support of this view, two recent studies have shown that cell migration through tight constrictions induces nuclear envelope rupture in the squeezed nuclei 108, 109 . After persisting for many hours, the chromatin bridges are resolved by 3ʹ repair exonuclease 1 (TREX1) (FIG. 5b) , a highly abundant and widely expressed 3ʹ exonuclease that degrades DNA species in the cyto plasm [110] [111] [112] [113] . TREX1 seems to gain access to the chroma tin bridge during nuclear envelope rupture may preferentially attack the DNA in the chromatin bridges because they lack the nucleosomes that normally repress TREX1 activity 3 . The exonuclease creates exten sive singlestranded DNA in chromatin bridges, leading to an accumulation of the singlestranded DNAbinding protein replication protein A (RPA) on the bridges (FIG. 5b) . The nicks in the doublestranded DNA that allow TREX1 to initiate resection were shown to exist in chromatin bridges 114 , but their source is unknown. Eventually, TREX1 digestion is thought to resolve the chromatin bridge once the resection of the Watson and Crick strands of the DNA converges.
Following chromatin bridge resolution, the remnants of the dicentric chromosome are reincorporated back into the nuclear genome, but continue to be marked by the presence of RPA, indicating that singlestranded DNA persists 3 . As the RPA mark usually dissipates within one cell cycle, repair of the fragmented dicentric chromosome is presumed to occur during this period 3 . The exact repair pathways that are responsible for generating the chromothriptic product have not yet been determined.
Fragmentation of chromatin bridge DNA by TREX1 could explain the regional DNA breaks that are typical of chromothripsis because only the portion of the dicentric chromosome residing inside the chromatin bridge is attacked by TREX1. Moreover, the repair of these frag ments in the primary nucleus is consistent with the cata strophic, but localized, rearrangements that are observed in chromothripsis (FIG. 5c) .
The observation that dicentric chromosomes persist through mitosis intact, suffer extensive fragmentation and give rise to chromothripsis is not in conflict with a telomeric origin of BFB cycles. Chromatin bridges can be resolved even in the absence of TREX1, indi cating that other mechanisms are at work 3 . Potentially, a TREX1independent pathway for bridge resolution could involve a nuclease that makes a single DSB and does not fragment the chromatin in the bridge. Such a broken dicentric chromosome could initiate BFB cycles by fusing the broken end with another broken end or, by chromatin bridges undergo frequent nuclear envelope (NE) rupture in interphase (NERDI), resulting in the accumulation of 3ʹ repair exonuclease 1 (TREX1) on bridge DNA. TREX1-mediated resection of DNA leads to the formation of single-stranded DNA (ssDNA), which is bound by replication protein A (RPA), and bridge resolution. Bridge fragments are internalized into the nucleus where they remain associated with RPA for approximately 24 hours. c | Part of the dicentric chromosome that is present in the chromatin bridge undergoes extensive fragmentation followed by haphazard repair, which yields a chromothriptic chromosome in which many original chromosome fragments are lost and retained fragments are present in seemingly random order and orientation. Chromothriptic breakpoints are frequently associated with kataegis mutation clusters.
Hyper-triploid karyotype
A genome that contains more than three (3N) but less than four (4N) sets of chromosomes.
instability in TREX1deficient cells progressing through telomere crisis.
Another source of chromothripsis in cancer may be chromosomes that missegregate into micronuclei. The chromosome in a micronucleus experiences DNA damage, extensive fragmentation and subsequent repair, leading to shattering of the entire chromosome 115, 116 . In addition, it was recently shown that simultaneous TRF2 depletion and inhibition of the spindle assembly check point kinase MPS1 can also result in chromothripsis, but the precise molecular pathway is not clear 117, 118 . Kataegis. Chromothripsis induced by experimental telo mere crisis is often accompanied by kataegis (FIG. 5c) . Kataegis is a hypermutation pattern of clustered C>T and C>G changes at TpC dinucleotides 119 . Kataegis is thought to result from the activity of the apolipo protein B mRNAediting catalytic subunit (APOBEC) family of enzymes [120] [121] [122] , which can deaminate cytosine residues to generate uracil, and therefore act as muta tors 123 . Many APOBECs are active in the cytoplasm, where they restrict RNA and DNA virus infection, most notably HIV, and other parasitic genomes, thereby con tributing to an innate retroviral defence 124 . APOBECs preferentially target singlestranded DNA, and can produce a cluster of strandcoordinated mutations that affect cytosine bases in the same (Watson or Crick) strand. Consistent with APOBEC activity, kataegis is found at the breakpoints of chromothriptic rearrange ments created by telomere crisis 3 . A possible explanation for this observation is that the extensive singlestranded DNA that accumulates following TREX1mediated resection serves as a substrate for APOBEC deaminases.
Telomere-driven tetraploidy. Finally, telomere crisis can induce tetraploidization (doubling the set of chromo somes) 8, 9 , which is inferred to be a frequent event during the development of human cancers 125 . Many human tumour cell lines have a neartetraploid or hyper-triploid karyotype, which is indicative of past tetra ploidization 125 . Tetraploidization can promote tumori genesis 9, [125] [126] [127] [128] [129] [130] [131] [132] [133] , and tetraploid cells have a high toler ance of chromosome missegregation and resilience to chromosomal instability 134 . Tetraploidization can be induced in cells that lack the p53 and RB pathways, which have a high load of dysfunctional telomeres 8,9 (FIG. 6) . The mechanism of tetraploidization involves persistent ATMdependent and/or ATRdependent signalling induced by irrepar ably damaged telomeres. This signalling leads to a prolonged G2 phase and ultimately a bypass of mitosis and entry into a G1like state. A second S phase then results in wholegenome reduplication and tetraploidy. Tetraploidization is observed following experi mental inactivation of shelterin and in p53deficient and RBdeficient human cells undergoing telomere crisis. 
Usual ductal hyperplasia
A benign overgrowth of cells that line the ducts or milk glands and is associated with an elevated risk of breast cancer.
Ductal carcinoma in situ
A noninvasive, early form of breast cancer characterized by proliferative, malignant cells that are confined to the milk duct.
Alternative lengthening of telomeres
A telomere lengthening mechanism that relies on homologous recombinationmediated DNA copying to counteract telomere shortening.
The prevalence of telomere crisis in cancer. Telomere crisis may be a frequent event during the development of human epithelial cancers, which initially lack telo merase. Shorter telomeres are frequently observed in cancer relative to their adjacent normal tissue [135] [136] [137] [138] [139] [140] [141] [142] . Anaphase bridges, which can be formed by telomeretelomere fusion, have been observed in human cancer samples, including in earlystage colorectal tumours 52 . However, a consideration of anaphase bridges may over estimate the level of telomere dysfunction because they could also result from other defects, including errors in DNA decatenation 143 and cohesin resolution 144 . Telomere crisis in breast cancer has been particu larly well documented. An analysis of genome instabil ity and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS) 145 . This phen omenon is consistent with the higher rate of chromo some aber rations in DCIS than in UDH 146 , the shortened telomeres found in DCIS 147 and the activation of telomerase in DCIS 148 . Methods to directly detect the scars of prior telo mere crisis in cancer genomes have now been devel oped 75, 149, 150 . The telomere-telomere fusions that are typical of telomere crisis can be detected with a PCR based assay that uses correctly oriented primers situated in the subtelomeric DNA of two (or more) chromo some ends 75, 150 . Using this approach, evidence for past telomere crisis has been obtained in CLL as well as in breast cancer, colorectal adenomas and other solid tumours 75, 77, 78 . In colorectal cancer, telomere fusion occurs during the adenoma-carcinoma transition and may also be present before the occurrence of most somatic mutations 78 . These studies have also revealed a prognostic value to stratifying patients according to the length of the shortest telomeres -as determined by a PCR assay that measures individual telomere lengths -and the likelihood that telomere fusions will take place 151, 152 . In CLL and invasive ductal carcinoma of the breast, overall survival is shorter when the telomeres are in a size range expected to result in telomere fusions 151, 152 .
Telomerase activation. Telomerase activation is often accomplished through mutations in the TERT pro moter 57, 58 . These mutations are the most common mutations in noncoding sequences in cancer and are found in a long, and almost certainly growing, list of cancers [153] [154] [155] [156] [157] [158] . Similar to the inherited TERT promoter mutations, the sporadic mutations (-57A>C, -124C>T and -146C>T) occur near the transcription start site where they create de novo binding sites for ETS tran scription factors. An analysis of these mutations in urothelial cancers showed that they are correlated with higher levels of TERT mRNA and protein levels and enzymatic activity and with greater telomere length 159 . In glioblastomas, sporadic TERT mutations were shown to activate transcription by enabling the recruitment of the transcription factor GAbinding protein αchain (GABPA) 160 . Introduction of these mutations into embryonic stem cells prevented TERT silencing upon differentiation and resulted in increased telomerase activity that counters telomere shortening 25 . TERT promoter mutations are not the only mech anism by which telomerase activity can be restored or enhanced. In neuroblastoma, telomerase activity is increased by recurrent genomic rearrangements that pair the TERT coding sequence with strong enhancer elements, thereby defining a subgroup of patients with poor prognoses 60 . However, in many human cancers, the mechanism by which telomerase is upregulated is yet to be determined. Furthermore, although most human cancers (~90%) escape telomere crisis by activating telomerase 56 , a significant minority of cancers use an alternative telomere maintenance system, referred to as alternative lengthening of telomeres (ALT) 161 . ALT is associated with mutations in the chromatin remodeller αthalassaemia/mental retardation syndrome Xlinked (ATRX) both in vitro and in several human cancers, including glioblastomas [162] [163] [164] [165] . The observations that TERT promoter mutations are usually mutually exclu sive with mutations in ATRX support the notion that ALT may provide a telomeraseindependent escape from telomere crisis 166, 167 .
Telomere dysfunction following telomerase activation.
The types and severity of genome instability induced by dysfunctional telomeres can vary between transient and persistent telomere dysfunction. In mouse models, continued telomere dysfunction can constrain cancer progression, whereas telomerase reactivation allevi ates intratumoural DNA damage and leads to more aggressive tumour progression and metastasis 168 . However, some telomere dysfunction may persist even after telomerase activation and exit from telomere crisis. Changes in telomere length can occur owing to stochastic telomere loss, as has been demonstrated in squamous cell and bladder cell carcinoma cell lines 169, 170 , and ongoing telomere dysfunction has been found in cancer cells with ALT 162, 171 . Telomere loss at individual chromosome ends is sufficient to produce many of the rearrangements seen in telomere crisis and in cancer, including amplifications, LOH, translocations, chromo some nondisjunction during mitosis, and the formation of isochromosomes and ring chromosomes 170, 172 . Even limited telomere dysfunction can wreak havoc on the genome because instability at individual chromosome ends can be transferred to other chromosomes through nonreciprocal translocations 172, 173 . Telomeres in human cancer are often shorter than in normal tissues 135 . It is possible that this setting of short telomere length reflects selection for a telomere length distribution that affords a low level of genome instability without diminishing cell viability.
Perspectives
An attractive feature of telomere crisis as a source of genome instability in cancer is its transient nature. A mutator phenotype is favoured when extrinsic or intrinsic forces demand the generation of variants. This process can enable cancer cell populations to adapt Chromoplexy A class of complex DNA rearrangements frequently observed in prostate cancer, which is characterized by multiple chromatin rearrangements that arise in a highly interdependent manner.
rapidly to new challenges presented by shifting environ ments. However, persistence of a mutator phenotype comes at a cost because most mutations are deleteri ous to cellular fitness. The brief, or at least transient, episode of genomic instability offered by dysfunctional telomeres avoids a persistent mutator phenotype that might hamper cell proliferation 10 . Ultimately, telomer ase reactivation provides a route out of telomere crisis, stabilizing the genome and rescuing cellular fitness.
Although much has been learned in recent years about the role of telomere crisis in cancer development, many basic questions remain. The current list of known genome rearrangements in cancer that follow telomere crisis is probably not comprehensive. For example, telo mere crisis may contribute to chromoplexy, in which chains of translocations link several chromosomes in a temporally constrained event 174 . Bioinformatic methods to detect the remnants of telomere-telomere fusions in entire cancer genome sequencing data sets need to be developed to fully understand the relationship between chromosome fusion events and consequent chromo some rearrangements. Future studies will help to reveal the mechanisms underlying the complexity of the cancer genome, and with continued investment, these insights may be translated into valuable prognostic indicators and more effective treatments.
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